The metastasis of many cancers is facilitated by migration mode flexibility – i.e. the ability to undergo MAT and AMT transitions – and we hypothesize that high RBM3 expression impairs this flexibility by “locking” cells into a mesenchymal mode. The gene discussed is RBM3; the disease is cancer.